U.S. Physical Therapy, Inc.

As of June 30, 2026, U.S. Physical Therapy, Inc. carries a market capitalization of 895.42M, placing it among publicly traded companies globally. Its enterprise value stands at 1.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

U.S. Physical Therapy, Inc.'s next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, U.S. Physical Therapy, Inc. has 14.92M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 1.28, and the price-to-book ratio stands at 2.28.

As of June 30, 2026, U.S. Physical Therapy, Inc. trades at an EV/EBITDA multiple of 17.20 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.10 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 22.24 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. U.S. Physical Therapy, Inc. trades at an EV/FCF ratio of 23.63, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 1.49B versus a market cap of 895.42M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, U.S. Physical Therapy, Inc. maintains a current ratio of 1.27, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 50.32, indicating elevated leverage, while an interest coverage ratio of 9.19 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, U.S. Physical Therapy, Inc. posted a negative return on equity (ROE) of -1.70, meaning shareholder capital produced losses rather than profits. Return on invested capital (ROIC) comes in at 5.11 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) is negative at -0.66, reflecting losses generated across the asset base. Return on capital employed (ROCE) is negative at -5.22, pointing to unprofitable operations over the period. The company generates approximately 98,363.37 in revenue per employee across its workforce of 7,227.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, U.S. Physical Therapy, Inc. recorded 15.39M in income tax expense. That works out to an effective tax rate of 26.06, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 59.04M, leaving -7.05M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 20, 2026, U.S. Physical Therapy, Inc.'s stock has declined approximately 6.94% over the past 52 weeks. The 50-day moving average sits at 63.04, while the 200-day moving average is 64.19.

Over the twelve months ended June 30, 2026, U.S. Physical Therapy, Inc. generated 710.92M in revenue and converted that into -7.05M in net income, yielding earnings per share of 2.88. EBITDA reached 86.59M, while operating income came in at 69.04M.

As of June 30, 2026, U.S. Physical Therapy, Inc. holds 21.78M in cash and equivalents against 337.68M in total debt, resulting in a net debt position of 170.80M. Total book value stands at 392.71M, with working capital of 26.05M providing operational flexibility.

U.S. Physical Therapy, Inc. produced 72.69M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -16.61M in capital expenditures, free cash flow totaled 56.08M - equivalent to 3.70 per share.

Over the twelve months ended June 30, 2026, U.S. Physical Therapy, Inc. posted a gross margin of 18.68, reflecting its pricing power and cost economics. The operating margin of 9.71 and net profit margin of -0.99 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, U.S. Physical Therapy, Inc. paid dividends of 0.79 per share. The dividend payout ratio of 12.69 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.17, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.80, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to U.S. Physical Therapy, Inc. shareholders.

U.S. Physical Therapy, Inc.'s most recent stock split took place on June 29, 2001 with a 2:3 split ratio.

As of June 30, 2026, U.S. Physical Therapy, Inc. has an Altman Z-Score of 5.23, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.